Companies: 10,795·Total market cap: $144.5T
Neuronetics, Inc.

Neuronetics, Inc.

STIMNASDAQHealthcare● Active
$1.28
$-0.01(-0.78%)
Market Cap$89072384
P/E Ratio
52W High$4.85
52W Low$0.8
Overview

Neuronetics, Inc. (STIM) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · STIM · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($0.04B)($0.04B)($0.03B)($0.04B)($0.03B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.01B$0.01B$0.01B$0.01B$0.01B
Change in Working Capital$0.01B($0.01B)($0.01B)($0.01B)($0.01B)
Net Cash from Operations($0.02B)($0.03B)($0.03B)($0.03B)($0.03B)
Investing Activities
Capital Expenditure($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Purchases of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Sales of Investments($0.00B)$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing($0.00B)($0.00B)($0.00B)$0.01B($0.01B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.01B($0.00B)$0.02B$0.00B$0.00B
Net Cash from Financing$0.04B($0.01B)$0.02B$0.00B$0.08B
Free Cash Flow
Free Cash Flow($0.02B)($0.03B)($0.03B)($0.03B)($0.03B)
FCF Margin %(computed)-14.20%-43.35%-48.22%-52.15%-54.85%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more Neuronetics, Inc. data

About Neuronetics, Inc. (STIM) Cash Flow Statement

Neuronetics, Inc. generated operating cash flow of ($0.02B) and free cash flow of ($0.02B) for 2025 — a FCF margin of -14.20%. Capital expenditure was ($0.00B).

Frequently asked questions

STIM · 4 questions

Neuronetics, Inc. generated free cash flow of ($0.02B) for 2025, up 34.8% year-over-year.

STIM free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10